AbbVie Inc.

History

Year	Detail
2013	AbbVie celebrated launch as new biopharmaceutical company..
2014	AbbVie announced novel collaboration on aging with Calico.
2014	The first medicine developed independently by AbbVie for chronic HCV was approved in the U.S.
2015	U.S. FDA approval for the treatment of moderate to severe hidradenitis suppurativa.
2016	AbbVie opened the Cambridge Research Center.
2017	MAVIRET and MAVYRET (glecaprevir/pibrentasvir) was approved in U.S., European Union and Japan.
2020	AbbVie acquired Allergan.
2021	AbbVie opens new facility in the Bay Area.
2022	AbbVie and the North Chicago Community Unit School District 187 opened the new Neal Math and Science Academy.
2024	AbbVie and OSE Immunotherapeutics announce partnership to develop a novel Monoclonal Antibody for the treatment of Chronic Inflammation.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.